The unmet need for better risk stratification of non-proliferative diabetic retinopathy
- PMID: 30474144
- PMCID: PMC6587728
- DOI: 10.1111/dme.13868
The unmet need for better risk stratification of non-proliferative diabetic retinopathy
Abstract
Diabetic retinopathy is a common microvascular complication of diabetes and remains one of the leading causes of preventable blindness in working-age people. Non-proliferative diabetic retinopathy is the earliest stage of diabetic retinopathy and is typically asymptomatic. Currently, the severity of diabetic retinopathy is assessed using semi-quantitative grading systems based on the presence or absence of retinal lesions. These methods are well validated, but do not predict those at high risk of rapid progression to sight-threatening diabetic retinopathy; therefore, new approaches for identifying these people are a current unmet need. We evaluated published data reporting the lesion characteristics associated with different progression profiles in people with non-proliferative diabetic retinopathy. Based on these findings, we propose that additional assessments of features of non-proliferative diabetic retinopathy lesions may help to stratify people based on the likelihood of rapid progression. In addition to the current classification, the following measurements should be considered: the shape and size of lesions; whether lesions are angiogenic in origin; the location of lesions, including predominantly peripheral lesions; and lesion turnover and dynamics. For lesions commonly seen in hypertensive retinopathy, a detailed assessment of potential concomitant diseases is also recommended. We believe that natural history studies of these changes will help characterize these non-proliferative diabetic retinopathy progression profiles and advance our understanding of the pathogenesis of diabetic retinopathy in order to individualize management of people with diabetic retinopathy.
© 2019 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
References
-
- International Diabetes Federation . IDF Diabetes Atlas. 8th edn. 2017. Available at http://www.diabetesatlas.org/ Last accessed 26 June 2018.
-
- Ahsan H. Diabetic retinopathy –biomolecules and multiple pathophysiology. Diabetes Metab Syndr 2015; 9: 51–54. - PubMed
-
- Santos AR, Ribeiro L, Bandello F, Lattanzio R, Egan C, Frydkjaer‐Olsen U et al Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross‐sectional analyses of baseline data of the EUROCONDOR project. Diabetes 2017; 66: 2503–2510. - PubMed
-
- Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond) 2009; 23: 1496–1508. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
